TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 79 filers reported holding TRINITY BIOTECH PLC in Q2 2016. The put-call ratio across all filers is 3.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,565,000 | +16.6% | 496,600 | 0.0% | 0.01% | +9.1% |
| Q2 2016 | $5,631,000 | -1.4% | 496,600 | 0.0% | 0.01% | -8.3% |
| Q1 2016 | $5,711,000 | -2.2% | 496,600 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $5,840,000 | +12.7% | 496,600 | +9.6% | 0.01% | +9.1% |
| Q3 2015 | $5,182,000 | -36.4% | 453,000 | +0.1% | 0.01% | -31.2% |
| Q2 2015 | $8,152,000 | -5.6% | 452,400 | -1.5% | 0.02% | -5.9% |
| Q1 2015 | $8,640,000 | +5.6% | 459,100 | -1.8% | 0.02% | +6.2% |
| Q4 2014 | $8,182,000 | -99.9% | 467,300 | 0.0% | 0.02% | +45.5% |
| Q3 2014 | $8,537,571,000 | -18.8% | 467,300 | +2.3% | 0.01% | -15.4% |
| Q2 2014 | $10,520,104,000 | +93.4% | 456,800 | +103.5% | 0.01% | +116.7% |
| Q1 2014 | $5,439,635,000 | – | 224,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |